Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy
- 6 June 2018
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 37 (1) , 173-179
Abstract
To validate the relationship between ABO blood type and risk of VTE post-RC in a large retrospective database.Keywords
This publication has 30 references indexed in Scilit:
- Non-O Blood Type Is the Commonest Genetic Risk Factor for VTE: Results from a Meta-Analysis of the LiteratureSeminars in Thrombosis and Hemostasis, 2012
- Variation in thromboembolic complications among patients undergoing commonly performed cancer operationsJournal of Vascular Surgery, 2012
- von Willebrand factor–mediated platelet adhesion is critical for deep vein thrombosis in mouse modelsBlood, 2011
- Prolonged thromboprophylaxis with Low Molecular Weight heparin for abdominal or pelvic surgeryCochrane Database of Systematic Reviews, 2009
- A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factorBlood, 2008
- von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosisJournal of Thrombosis and Haemostasis, 2006
- ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?Transfusion, 2006
- A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer SurgeryAnnals of Surgery, 2006
- Radical CystectomyBJU International, 2004
- Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for CancerNew England Journal of Medicine, 2002